BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1298@pharmaconomics
DTSTAMP:20260707T042221Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:VALN Phase 2 — S4V2
DESCRIPTION:Phase 2 trial results for S4V2 in Shigellosis are due Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1836564/000162828026019159/a2026_03x18xfyx2025xresult.htm\n\nTrack it: https://pharmaconomics.com/e/1298
URL:https://pharmaconomics.com/e/1298
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VALN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR